Neutralizing Activity against SARS-CoV-2 Variants Among samples obtained from persons
who had received the mRNA-1273 or BNT162b2 vaccines, neutralizing antibody titers …

Objectives The emergence of new variants of concern (VOCs) of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit …

Vaccination after SARS-CoV-2 Infection Six patients previously infected with the original
SARS-CoV-2 virus received the BNT162b2 vaccine. Before vaccination, they had …

The capacity of convalescent and vaccine-elicited sera and monoclonal antibodies (mAb) to
neutralize SARS-CoV-2 variants is currently of high relevance to assess the protection …

Cross-Reactive Neutralization of SARS-CoV-2 Variants An analysis of cross-reactive viral
binding and neutralization of emerging SARS-CoV-2 variants suggests that the mRNA-1273 …

Variant SARS-CoV-2 and the mRNA-1273 Vaccine How well do serum samples from
persons vaccinated with the mRNA-1273 vaccine neutralize the P. 1 lineage, the B. 1.1. 7 …

Importance Although 2 and 3 doses of vaccine have been implemented against the SARS-
CoV-2 pandemic, the level of immunity achieved by these additional vaccinations remains …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B. 1.1. 7 and B. 1.351
variants were first identified in the United Kingdom and South Africa, respectively, and have …

SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
has led to growing concerns over increased transmissibility and the ability of some variants …